Today: 7 February 2026
Subscribe

Biogen Stock Slides on Q3 Beat as Guidance Cut Shocks Investors

Biogen Stock Slides on Q3 Beat as Guidance Cut Shocks Investors

Biogen Inc. (Nasdaq: BIIB) is a leading neuroscience biotech known for multiple sclerosis and rare-disease therapiests2.tech. On Oct. 30, 2025 the stock dipped after a mixed earnings release. The company beat Q3 expectations – adjusted EPS $4.81 vs. $3.88 est and $2.53 B revenue vs. $2.34 B estng.investing.com – but lowered its full-year outlook. Biogen now expects 2025 non-GAAP EPS of $14.50–$15.00 (previously $15.50–16.00), citing an anticipated ~$1.25 per-share charge in Q4 for recent R&D dealsreuters.comreuters.com. CEO Chris Viehbacher spun the quarter positively, noting “we delivered another quarter of strong financial performance driven by … momentum in our launch products [and] resilience
30 October 2025
·····
GLE Stock Skyrockets 50%: Key Facts & What’s Next

GLE Stock Skyrockets 50%: Key Facts & What’s Next

Market context: Hong Kong’s stock market has been booming in 2025 (Hang Seng +35% YTD)ts2.tech. GLE’s recent spike (circled) comes against a broad tech rally, but its own financials remain thin. Trading Rundown (Last Few Days) In late Oct 2025, GLE’s stock was trading in the $0.62–0.70 rangestockanalysis.com. On Oct 29 it closed at $0.6526stockanalysis.com (up ~3.2% that day), which was already a rebound from earlier October levels. Suddenly after the market closed, the price jumped by over 40% to about $0.92stockanalysis.com. By early Oct 30 it hit roughly $0.995stocktitan.net. Trading volume spiked (Oct 29 volume ~215K sharesstockanalysis.com). No official
30 October 2025
····
Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

Cigna (CI) Rallies on Q3 Beat & Rebate-Free Drug Plan – Is a 25% Upside in Sight?

CI Stock Price and Recent Trend Cigna’s stock has pulled back modestly in late October after a strong run earlier in the year. According to market data, CI closed at $299.12 on Oct 29, 2025, down about 3% from the previous closestockanalysis.com. The dip followed weakness in broader managed-care stocks amid concerns about healthcare costs and policy. In pre-market trading Oct 30, CI rebounded to about $303 (up ~1.3%)reuters.com. Over the past year, CI shares have traded between roughly $257 and $350stockanalysis.com, reflecting volatility in the insurance sector. Despite the pullback, Cigna’s valuation metrics remain attractive: at ~16x forward earnings,
30 October 2025
····
Beauty Rebound: Estée Lauder Soars After Stunning Earnings Surprise

Beauty Rebound: Estée Lauder Soars After Stunning Earnings Surprise

Stock Performance Today Estée Lauder shares jumped in early trading after the earnings release. Reuters data show EL pre-market up ~5% to $102.26tradingview.com. By midday Oct. 30 the stock was about $97.36, down ~1.4% on the dayreuters.com. (Over the past six months, the stock has rallied roughly 60% amid optimism about a rebound in China and travel retailglobalcosmeticsnews.com.) Trading updates noted EL was a top mover on Oct 13 (+6–7%) after Goldman’s upgradets2.techts2.tech. Overall, EL is now up nearly 30% year-to-datetradingview.com. Strong Q1 Results Drive the Rally The company’s Q1 results far exceeded forecasts. As reported, net sales were $3.481B,
30 October 2025
·
Hot GDP Surprise Shatters Wall Street’s Rally – Stocks Slide on Fed Jitters (Sept 25, 2025)

Stock Market Rollercoaster: Tech Stocks Tumble After Trump-Xi Trade Truce & Fed’s Hawkish Signals

Market Recap Global stocks wobbled this week on the twin shocks of trade news and monetary policy. In Busan on Oct. 30, Trump met Xi Jinping and touted a deal to trim U.S.–China tariffs, resume Chinese soybean and energy imports, and keep rare-earths exports flowingreuters.com. Beijing promptly agreed to suspend some counter-tariffs for a year. Yet traders remained wary. “A good Trump/Xi meeting was in the price…we’ve simply got confirmation of that,” noted Daiwa’s Chris Scicluna, implying markets had already anticipated a positive outcomereuters.com. In fact, stocks “fell on concerns the truce may prove fleeting” as details were scant. Meanwhile,
30 October 2025
···
Novo Nordisk (NVO) Stock Tanks as Weight-Loss Empire Faces Boardroom Coup and Fierce Rivalry

Novo Nordisk hijacks Pfizer’s Metsera deal with a $9B bid – obesity-drug war heats up

Novo’s counter-offer details Novo Nordisk’s proposal is unsolicited, meaning Metsera’s board and shareholders will now review it against Pfizer’s agreement. Novo emphasizes that Metsera’s experimental therapies would be “complementary” to its own obesity portfolioreuters.com. According to MarketScreener (Dow Jones Newswires), the bid is $56.50 in cash per Metsera share plus $21.25 in milestone CVRsmarketscreener.com. By contrast, Pfizer’s September deal was $4.9B upfront (about $28.50/share) plus CVRs, for up to ~$7.3Bts2.techreuters.com. Novo’s offer thus values the company at roughly $6.5B upfront, sweetened to ~$9B with earnouts. Novo’s CEO Maziar “Mike” Doustdar hailed the move as proof of the company’s ambition. In
30 October 2025
···
Merck (MRK) Stock Could Skyrocket: Key Drug Approvals & Analyst Targets Unveiled

Merck (MRK) Stock Dips on Earnings Beat — Will Pipeline Boost Spur a Rally?

Merck’s stock price dipped on Oct 30, 2025 even as it delivered a strong third-quarter report. The company posted $17.28 B in Q3 sales and $2.58 adjusted EPS – above analyst forecastsmarketscreener.com. Sales of Keytruda, its blockbuster cancer drug, grew about 10% (to $8.1 B)marketscreener.com, offsetting a drop in Gardasil vaccine revenue. Despite the beat, Merck narrowed its 2025 sales outlook (now $64.5–65.0 B) while slightly raising profit guidancemarketscreener.com, a cautious stance that likely weighed on the share price. Pipeline and Drug Approvals Drive Hopes Beyond the quarterly numbers, recent product news is energizing Merck’s outlook. In September 2025 the FDA approved Keytruda
30 October 2025
····
Cambium Networks (CMBM) Stock Soars 377% on Starlink Tie-Up — Delisting Threats Loom

Cambium Networks (CMBM) Stock Soars 377% on Starlink Tie-Up — Delisting Threats Loom

Starlink Integration Sends Stock Soaring On Oct 29 Cambium announced that its ONE Network solution now integrates SpaceX’s Starlink LEO satellite internet Prnewswire. The press release explained this enables “scalable management, visibility, and performance optimization” for enterprise Starlink connections, including multi-WAN bonding, advanced security, and centralized monitoring Prnewswire Benzinga. In other words, Cambium customers (e.g. schools, businesses, service providers) can now combine multiple Starlink links into their wired/wireless networks using Cambium’s cnMaestro and NSE platforms. Investors viewed the tie‑up as a game-changer. At market close on Oct 29, CMBM was $2.95, a +377% jump from the prior day Stockanalysis. (Just
30 October 2025
·····
VCI Global Stock Skyrockets 88% on AI-Crypto Token News: Microcap VCIG Rallies Afterhours

VCI Global Stock Skyrockets 88% on AI-Crypto Token News: Microcap VCIG Rallies Afterhours

Crypto-Token Deal Sparks After-Hours Rally On Oct. 29 after the market closed, VCI Global (NASDAQ: VCIG) announced that its unit Smart Bridge Technologies will solely issue and manage 1 billion XVIQ tokens – a new digital asset for AI infrastructure, GPU cloud services and real-world assetsglobenewswire.com. The press release outlined how Smart Bridge will oversee token issuance, a treasury and liquidity (e.g. staking, reserve allocations) to generate fees from GPU services, cybersecurity, token settlement and moreglobenewswire.com. CEO Henry Chai said the mandate is “a pivotal step…[laying] the foundation for a digital financial infrastructure that connects AI, GPU, and real-world asset markets.”globenewswire.com.
30 October 2025
·····
Inside Samsung: How the Tech Giant is Dominating Every Industry It Touches

Samsung Stock Soars on AI Chip Boom – Q3 Earnings Crush Estimates

Stock Rallies on Robust Q3 Results Samsung’s share price climbed sharply on October 30 after it disclosed a surprise surge in Q3 earnings. The official results (released before market hours) showed revenue of about ₩86.1 trillion and operating profit of roughly ₩12.2 trillion for July–September, well above analysts’ forecastslivemint.comgurufocus.com. The memory chip business was the standout: Samsung said record AI-driven demand led its chip division to post double-digit profit growth. In response, Seoul trading saw Samsung shares spike over 3% on the news, outperforming the broader Kospi indexreuters.cominvesting.com. As one market observer noted, “the third-quarter earnings surprise came from the
30 October 2025
····
Bubble or Boom? Magnificent Seven Stocks Face Critical Earnings Showdown

Alphabet (GOOG) Hits Record High on Q3 Earnings Beat, AI Boom Fueling Rally

Alphabet Stock Soars to Record Highs Alphabet Inc.’s stock is on a tear heading into late October 2025. After this week’s earnings blowout, Alphabet’s Class C shares (NASDAQ: GOOG) surged to roughly $270, marking a fresh all-time highreuters.com. On October 20, the stock had already closed at a record ~$256, valuing the Google parent near the elite $3 trillion market-cap clubts2.tech. Now, with the post-earnings pop, Alphabet firmly joins Apple and Microsoft among tech’s $3 trillion heavyweights. Year-to-date, the stock has climbed about 30%, dramatically outpacing the S&P 500’s ~12% gaints2.tech. For context, Alphabet’s rally has made it one of 2025’s top-performing mega-cap tech
30 October 2025
····
Chipotle Stock Tumbles on Third Forecast Cut — Can the Burrito Chain Bounce Back?

Chipotle Stock Craters After Tepid Q3 Earnings – What’s Next for CMG?

Disappointing Q3 & Guidance Trim Drag Shares Chipotle’s official earnings release confirmed a mixed quarter. Revenue rose to $3.0 billion (+7.5% YoY) but narrowly missed expectations (~$3.03 billion), as comp sales growth (0.3%) failed to offset weaker trafficts2.techir.chipotle.com. EPS came in at $0.29 (GAAP and adjusted), beating last year’s $0.28ir.chipotle.com but just matching analysts’ consensusmarketbeat.com. The report noted softer transactions – partly self-inflicted and largely driven by budget-conscious consumers – among households earning <$100k (40% of Chipotle’s sales) and 25–35-year-olds. CEO Scott Boatwright acknowledged “a massive pullback of our core audience,” saying “we’re not losing [those customers] to competition, we’re losing them
30 October 2025
····
1 … 2,298 2,299 2,300 2,301 2,302 … 2,706

Stock Market Today

Nebius (NBIS) stock jumps 16% into weekend as AI trade whipsaws; earnings next week in focus

Nebius (NBIS) stock jumps 16% into weekend as AI trade whipsaws; earnings next week in focus

7 February 2026
Nebius shares jumped 16.6% to $86.10 on Friday, rebounding from a 10.3% drop Thursday. The company will report fourth-quarter and full-year 2025 results before the market opens on Feb. 12. U.S. jobs and inflation data are due next week after a delay from a government shutdown. Recent swings in Nebius stock followed volatility in AI-linked tech names after Alphabet’s spending update.
Go toTop